NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in NextCure, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −8 vs. Q1 2025
- Shares held
- 10.5M
- −4.82M (−31.4%) vs. Q1 2025
- Total value
- $5.65M
- −$1.73M (−23.5%) vs. Q1 2025
- New holders
- 2
- 6 more added
- Sold out
- 10
- 10 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 2,671,856 | $1.23M | 0.08% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 2,302,598 | $1.06M | 0.16% | 00.0% | Unchanged |
| Pfizer Inc | 157,646 | $870.2K | 0.15% | −1,734,117−91.7% | Reduced |
| Citigroup Inc | 1,025,469 | $471.7K | 0.00% | −393,901−27.8% | Reduced |
| Vanguard Group Inc | 872,020 | $401.1K | 0.00% | −115,304−11.7% | Reduced |
| Cable Car Capital LLC | 758,141 | $348.7K | 0.15% | +88,040+13.1% | Added |
| Renaissance Technologies LLC | 500,935 | $230.4K | 0.00% | +20,973+4.4% | Added |
| Acadian Asset Management LLC | 488,440 | $223.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 376,025 | $173.0K | 0.00% | −180,661−32.5% | Reduced |
| Cardiff Park Advisors, LLC | 262,000 | $120.5K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 229,707 | $105.7K | 0.00% | −6,478−2.7% | Reduced |
| Macquarie Group Ltd | 150,000 | $69.0K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 131,300 | $60.4K | 0.02% | +1,300+1.0% | Added |
| ADAR1 Capital Management, LLC | 118,012 | $54.3K | 0.01% | −2,000−1.7% | Reduced |
| Armistice Capital, LLC | 104,000 | $47.8K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 67,518 | $31.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 65,392 | $30.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 58,845 | $27.1K | 0.00% | −31,798−35.1% | Reduced |
| Northern Trust Corp | 47,493 | $21.8K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 45,000 | $20.7K | 0.02% | +20,000+80.0% | Added |
| Ieq Capital, LLC | 37,342 | $17.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 29,503 | $13.6K | 0.00% | +29,503 | New |
| HSBC Holdings PLC | 17,257 | $8.09K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 13,835 | $6.36K | 0.00% | −5,100−26.9% | Reduced |
| UBS Group AG | 12,299 | $5.66K | 0.00% | +3,762+44.1% | Added |
| Tower Research Capital LLC (TRC) | 1,528 | $703 | 0.00% | −341−18.2% | Reduced |
| JPMorgan Chase & Co | 756 | $348 | 0.00% | −51−6.3% | Reduced |
| BNP Paribas Arbitrage, SA | 385 | $177 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 273 | $125 | 0.00% | +11+4.2% | Added |
| Simplex Trading, LLC | 920 | $0 | 0.00% | +920 | New |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,141,200−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −404,144−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −315,180−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −273,536−100.0% | Sold out |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −265,442−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −51,700−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,198−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,028−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,272−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −12,175−100.0% | Sold out |